Leo International Precision Health AG publishes new voting rights figures
On July 30, 2026, Leo International Precision Health AG published an official notification regarding the total number of its voting rights. This announcement was made in accordance with Section 41 of the German Securities Trading Act (WpHG).
With this publication, the company is fulfilling its legal obligation to provide transparency regarding voting rights. The purpose of the notification is to disseminate this information throughout Europe in order to inform investors and the public about the company's current structure.
The Securities Trading Act requires listed companies to report changes in their voting rights on a regular basis. This serves to protect investors and ensures that all market participants have access to the same level of information.
Leo International Precision Health AG operates in the health technology sector. Such notifications are important for shareholders, as they can provide insight into the distribution of voting rights and potential changes in the ownership structure.
For interested investors and market observers, the notification is available through official financial reporting channels. Further details regarding the exact figures can be found in the company's corresponding documents.